BET抑制剂I-BET151抑制角质形成细胞炎症与细胞周期基因
研究探讨BET蛋白是否调控角质形成细胞炎症反应。原代人角质形成细胞经TNF/IL-17刺激后,BET蛋白(BRD2/3/4)募集至IL-6/-8启动子区并激活PolII,I-BET151可阻断这些效应。BRD4/p65在IL-6启动子的富集高于IL-8,转录组分析显示I-BET151调控细胞周期、凋亡、增殖和先天免疫相关基因,与银屑病相关基因重叠。
要点
- TNF/IL-17诱导角质形成细胞组蛋白高乙酰化及BET蛋白募集至IL-6/-8启动子。
- I-BET151阻断BET蛋白募集、PolII激活及炎症基因表达。
- BRD4/p65在IL-6启动子富集高于IL-8,提示BRD4整合NF-κB炎症信号。
核心结论
- BET蛋白调控角质形成细胞炎症基因转录,I-BET151抑制炎症和细胞周期相关基因,提示BET蛋白是炎症性皮肤病潜在治疗靶点。
研究设计与样本
- 原代人角质形成细胞经TNF/IL-17刺激并用BET抑制剂I-BET151处理,进行转录组学分析。
主要发现
- TNF/IL-17诱导组蛋白高乙酰化、BET蛋白(BRD2/3/4)募集至IL-6/-8启动子及PolII(S2P)激活,与基因表达增加相关,I-BET151可阻断这些效应。
- BRD4/p65在IL-6启动子的富集高于IL-8启动子。
- I-BET151调控细胞周期、凋亡、细胞增殖和先天免疫反应相关基因,与银屑病相关基因重叠。
临床怎么用
- BET抑制剂可能通过靶向角质形成细胞先天免疫反应治疗炎症性皮肤病,BRD4或为关键干预节点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bromodomain containing BET proteins are druggable proteins which bind acetylated chromatin and are implicated in dysregulated gene expression in chronic inflammatory disorders. We set out to test whether BET proteins regulate inflammatory responses in keratinocytes, which are key effector cells in cutaneous inflammation. Primary human keratinocytes were stimulated with TNF/IL-17 and treated with BET inhibitor (I-BET151). TNF/IL-17 induced histone hyperacetylation, recruitment of BET proteins (BRD2/3/4) to the promoter regions of IL-6/-8 and activation of PolII (S2P) which correlated with increased gene expression. These effects were blocked by I-BET151. Notably a greater enrichment of BRD4/p65 was observed at the IL-6 compared to the IL-8 promoter. Transcriptomics analysis showed I-BET151 treatment modulated gene expression involved in cell cycle, apoptosis, cell proliferation and innate immune responses, which overlapped with psoriasis-associated genes. These results demonstrate disease-relevant stimuli induced dynamic histone modifications and recruitment of BET proteins at inflammatory gene loci in human keratinocytes. New evidence for BRD4/p65 enrichment at the IL-6 promoter indicated BRD4 may be a critical factor in integrating inflammatory stimuli via NF-κB in cutaneous inflammation. Inhibition of these responses by I-BET151 highlighted BET proteins as regulators of keratinocyte innate immune responses and potential therapeutic targets in inflammatory skin disease.
引用
- Wu KCP, Harker NR, Cockell SJ, et al. Differential BET protein recruitment to IL6 and IL8 promoters and suppression of inflammatory and cell cycle genes by BET inhibitor in keratinocytes. J Invest Dermatol. 2026. PMID: 42732788. doi:10.1016/j.jid.2026.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。